The Latest Breaking News from CAH

The S&P 500 Index ($SPX ) (SPY ) today is up +0.72%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.13%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.64%. September E-mini S&P futures (ESU25 ) are up +0.63%, and September E-mini Nasdaq futures...

Cardinal Health Inc. (NYSE:CAH) shares fell Tuesday after the company reported mixed fourth-quarter results and announced a $1.9 billion deal to acquire Solaris Health.

These three dividend companies all share one commonality: near-perfect buy ratings and breakout potential.

Due to Cencora’s strong performance relative to the broader Dow over the past year, Wall Street analysts remain bullish about the stock’s prospects.

These three dividend stocks easily beat the S&P 500's return in 2025 while offering predictable earnings and dividend growth.

Cardinal Health has delivered robust gains over the past year, outperforming the broader market, and analysts are highly bullish on its outlook.

Cardinal Health is scheduled to announce its third-quarter results next month, with analysts anticipating a single-digit earnings growth.

Summary Cardinal Health (CAH) shows strong technical buy signals, with a 3.95% gain since the Trend Seeker buy signal on 3/18 and consistent price appreciation. The company operates globally, providing a wide range of healthcare services and products, including pharmaceuticals, medical supplies, and radiopharmaceuticals. Barchart's technical indicators highlight CAH's positive...

Cardinal Health has surpassed the broader healthcare sector’s performance over the past year, and analysts are expressing continued confidence in its growth potential.